SCHEMBL30821

SCHEMBL30821

[CH2]C1CCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1892822 1.00
SCHEMBL1676000 1.00
Hydrochloric Acid SCHEMBL29090150 0.97
SCHEMBL156910 0.90
SCHEMBL944912 0.90
SCHEMBL943559 0.90
SCHEMBL446149 0.88
SCHEMBL446417 0.88
SCHEMBL28221014 0.88 CYP2D6 (0.37)
SCHEMBL20399494 0.88

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1525 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024145505-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS ACRIVON THERAPEUTICS, INC. (US) 2024-07-04 WO claimed
WO-2024046406-A1 ALKYLIDENE CARBAMATE AS KRAS INHIBITORS NIKANG THERAPEUTICS, INC. (US) 2024-03-07 WO claimed
WO-2024045066-A1 ALKYLIDENE CARBAMATE AS KRAS INHIBITORS NIKANG THERAPEUTICS, INC. (US) 2024-03-07 WO claimed
WO-2023134733-A1 TREATMENT OF SIGNS, SYMPTOMS AND/OR COMPLICATIONS OF VIRAL, BACTERIAL, PROTOZOAL, AND/OR FUNGAL INFECTIONS BY HIGH PENETRATION PRODRUGS TECHFIELDS PHARMA CO., LTD. (CN) 2023-07-20 WO claimed
US-20230226062-A1 HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS INCYTE CORPORATION 2023-07-20 US claimed
US-20230192619-A1 Processes for the Preparation of a Kinase Inhibitor EXELIXIS, INC. 2023-06-22 US claimed
US-RE49481-E1 Compounds for the treatment and prophylaxis of respiratory syncytial virus disease HOFFMANN-LA ROCHE INC. (US) 2023-04-04 US claimed
EP-4143169-A1 PROCESSES FOR THE PREPARATION OF A KINASE INHIBITOR Exelixis, Inc. (US) 2023-03-08 EP claimed
CN-115461328-A Process for preparing kinase inhibitors 埃克塞里艾克西斯公司 2022-12-09 CN claimed
WO-2021222673-A1 PROCESSES FOR THE PREPARATION OF A KINASE INHIBITOR EXELIXIS, INC. (US) 2021-11-04 WO claimed
EP-0370236-A1 Indolocarbazole derivatives, processes for their preparation and their use as medicaments GÖDECKE AKTIENGESELLSCHAFT (DE) 1990-05-30 EP claimed
EP-0147044-B1 BENZOFURANCARBOXAMIDES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM ADRIA LABORATORIES INC. (US) 1990-04-25 EP claimed
US-4912107-A Pyrrolocarbazole derivatives, compositions containing them, and methods for using them GOEDECKE AKTIENGESELLSCHAFT (DE) 1990-03-27 US claimed
US-4888353-A Carboxamides useful as antiemetic or antipsychotic agents ERBAMONT, INC. (US) 1989-12-19 US claimed
EP-0131374-B1 PROCESS AND INTERMEDIATES FOR THE PREPARATION OF PENEM DERIVATIVES PFIZER INC. (US) 1988-11-23 EP claimed
EP-0234872-A1 Carboxamides useful as antiemetic or antipsychotic agents Erbamont Inc. (US) 1987-09-02 EP claimed
US-4619783-A BACTERICIDES PFIZER INC. (US) 1986-10-28 US claimed
EP-0152255-A2 New renin-inhibitory peptides and their use SANKYO COMPANY LIMITED (JP) 1985-08-21 EP claimed
EP-0147044-A2 Benzofurancarboxamides, process for their preparation and pharmaceutical preparations containing them ADRIA LABORATORIES INC. (US) 1985-07-03 EP claimed
EP-0131374-A1 Process and intermediates for the preparation of penem derivatives PFIZER INC. (US) 1985-01-16 EP claimed